SAI Life Sciences

Activities: Manufacturing Research & Development

Trending Articles

  1. Thermo Fisher Scientific officially opens US oral solid dose testing and R&D facility The company's further expansion in the Bend, Oregon area will assist its pharmaceutical clients in the early development of oral solid dosage (OSD) forms
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    CDMO insights: development and manufacture of a highly potent OSD product In today’s pharmaceutical landscape, contract development and manufacturing organisations (CDMOs) are ubiquitous. Prior to the CDMO boom in the 1990s, however, this wasn’t...
  3. Gerresheimer acquires Bormioli Pharma Group through Blitz LuxCo Sarl merger Gerresheimer and Bormioli Pharma will merge to provide the biotech and pharmaceutical industries with primary packaging solutions, dosing systems, closure solutions and...
  4. Accumulus Synergy teams up with CEPI to expedite the vaccine regulatory approval process Through Accumulus' cloud-based technology, the two organisations aim to accelerate the accessibility of data for the regulatory approval process of vaccines globally, enhancing...
  5. Manufacturing Chemist Stand Side with Enzene Biosciences at CPHI Milan 2024 We discover what exhibitors at CPHI Milan 2024 are showcasing LIVE!

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Manufacturing

Sai Life Sciences to open discovery biology facility at R&D campus

The company's client base works across a set of therapeutic areas including oncology, CNS, antivirals, and inflammation
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Putting people at the core of meeting ever increasing healthcare expectation

The World Health Organization (WHO) defined health in its broader sense in its 1948 constitution as “a state of complete physical, mental and social well-being, and not merely the absence of disease or infirmity”; a substantial fraction of the waste in healthcare expenditure results from not knowing what works for particular patients in specific therapeutic indications
Manufacturing

Sai Life Sciences to exhibit at CPhI Worldwide 2017

SAI Life Sciences is a strategic contract development and manufacturing service provider, with a broad technology platform tailored to accelerate discovery, development and commercial supply of regulatory starting materials (RSM), intermediates and new chemical entities (NCE) of pharma and biotech companies
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Revolutionising the pharma supply chain

Establishing a globally competitive, compliant and efficient supply chain that can be managed by a smaller set of Big Pharma innovators is a key industry challenge
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Greater RSM scrutiny puts new constraints on supplier selection

The recent heightened scrutiny of Regulatory Starting Materials requires that manufacturers employ more sophisticated supplier selection criteria, argue Brian Scanlan, MD, Freedom Bioscience Solutions and Marcel Velterop, Chief Commercial Officer, SAI
Regulatory

SAI lays emphasis on RSM quality to ensure compliant API launches

The company has demonstrated an ability to deliver high quality RSMs conforming to the new ICH Q11 guidelines
Manufacturing

CPhI: SAI to emphasise RSM Quality and its new T3 facility

SAI welcomes visitors to Stand 5J10
Subscribe now